Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Clinical management of idiopathic mastalgia: a systematic review.

Hafiz SP, Barnes NLP, Kirwan CC.

J Prim Health Care. 2018 Dec;10(4):312-323. doi: 10.1071/HC18026.

PMID:
31039960
2.

The impact of immediate breast reconstruction on the time to delivery of adjuvant therapy: the iBRA-2 study.

O'Connell RL, Rattay T, Dave RV, Trickey A, Skillman J, Barnes NLP, Gardiner M, Harnett A, Potter S, Holcombe C; iBRA-2 Steering Group; Breast Reconstruction Research Collaborative.

Br J Cancer. 2019 Apr;120(9):883-895. doi: 10.1038/s41416-019-0438-1. Epub 2019 Mar 29.

PMID:
30923359
3.

Short-term safety outcomes of mastectomy and immediate implant-based breast reconstruction with and without mesh (iBRA): a multicentre, prospective cohort study.

Potter S, Conroy EJ, Cutress RI, Williamson PR, Whisker L, Thrush S, Skillman J, Barnes NLP, Mylvaganam S, Teasdale E, Jain A, Gardiner MD, Blazeby JM, Holcombe C; iBRA Steering Group; Breast Reconstruction Research Collaborative.

Lancet Oncol. 2019 Feb;20(2):254-266. doi: 10.1016/S1470-2045(18)30781-2. Epub 2019 Jan 9.

4.

Adherence to best practice consensus guidelines for implant-based breast reconstruction: Results from the iBRA national practice questionnaire survey.

Mylvaganam S, Conroy EJ, Williamson PR, Barnes NLP, Cutress RI, Gardiner MD, Jain A, Skillman JM, Thrush S, Whisker LJ, Blazeby JM, Potter S, Holcombe C; iBRA Steering Group; Breast Reconstruction Research Collaborative.

Eur J Surg Oncol. 2018 May;44(5):708-716. doi: 10.1016/j.ejso.2018.01.098. Epub 2018 Feb 7.

5.

Variation in the provision and practice of implant-based breast reconstruction in the UK: Results from the iBRA national practice questionnaire.

Mylvaganam S, Conroy E, Williamson PR, Barnes NLP, Cutress RI, Gardiner MD, Jain A, Skillman JM, Thrush S, Whisker LJ, Blazeby JM, Potter S, Holcombe C; iBRA Steering Group; Breast Reconstruction Research Collaborative.

Breast. 2017 Oct;35:182-190. doi: 10.1016/j.breast.2017.07.016. Epub 2017 Jul 30.

6.

The iBRA (implant breast reconstruction evaluation) study: protocol for a prospective multi-centre cohort study to inform the feasibility, design and conduct of a pragmatic randomised clinical trial comparing new techniques of implant-based breast reconstruction.

Potter S, Conroy EJ, Williamson PR, Thrush S, Whisker LJ, Skillman JM, Barnes NL, Cutress RI, Teasdale EM, Mills N, Mylvaganam S, Branford OA, McEvoy K, Jain A, Gardiner MD, Blazeby JM, Holcombe C; Breast Reconstruction Research Collaborative.

Pilot Feasibility Stud. 2016 Aug 4;2:41. eCollection 2016.

7.

Reply to: Letter Infection prevention in breast implant surgery - A review of the surgical evidence, guidelines and a checklist.

Topps AR, Barr SP, Barnes NL, Kirwan CC; Northwest Breast Surgical Research Collaborative.

Eur J Surg Oncol. 2016 Aug;42(8):1248. doi: 10.1016/j.ejso.2016.05.034. Epub 2016 Jun 14. No abstract available.

PMID:
27329370
8.

Infection prevention in breast implant surgery - A review of the surgical evidence, guidelines and a checklist.

Barr SP, Topps AR, Barnes NL, Henderson J, Hignett S, Teasdale RL, McKenna A, Harvey JR, Kirwan CC; Northwest Breast Surgical Research Collaborative.

Eur J Surg Oncol. 2016 May;42(5):591-603. doi: 10.1016/j.ejso.2016.02.240. Epub 2016 Feb 27. Review.

PMID:
27005885
9.

Molecular phenotypes of DCIS predict overall and invasive recurrence.

Williams KE, Barnes NL, Cramer A, Johnson R, Cheema K, Morris J, Howe M, Bundred NJ.

Ann Oncol. 2015 May;26(5):1019-25. doi: 10.1093/annonc/mdv062. Epub 2015 Feb 12.

PMID:
25678586
10.

Is axillary lymph node clearance required in node-positive breast cancer?

Bundred NJ, Barnes NL, Rutgers E, Donker M.

Nat Rev Clin Oncol. 2015 Jan;12(1):55-61. doi: 10.1038/nrclinonc.2014.188. Epub 2014 Nov 4. Review.

PMID:
25367714
11.

The frequency of presentation and clinico-pathological characteristics of symptomatic versus screen detected ductal carcinoma in situ of the breast.

Barnes NL, Dimopoulos N, Williams KE, Howe M, Bundred NJ.

Eur J Surg Oncol. 2014 Mar;40(3):249-54. doi: 10.1016/j.ejso.2013.12.013. Epub 2014 Jan 3.

PMID:
24433818
12.

Ductal carcinoma in situ of the breast.

Barnes NL, Ooi JL, Yarnold JR, Bundred NJ.

BMJ. 2012 Feb 29;344:e797. doi: 10.1136/bmj.e797. Review. No abstract available.

PMID:
22378935
13.

Quantitative analysis of over 20 years of golf course monitoring studies.

Baris RD, Cohen SZ, Barnes NL, Lam J, Ma Q.

Environ Toxicol Chem. 2010 Jun;29(6):1224-36. doi: 10.1002/etc.185. Review.

PMID:
20821564
14.

Intracellular targeting of copper-transporting ATPase ATP7A in a normal and Atp7b-/- kidney.

Linz R, Barnes NL, Zimnicka AM, Kaplan JH, Eipper B, Lutsenko S.

Am J Physiol Renal Physiol. 2008 Jan;294(1):F53-61. Epub 2007 Oct 10.

15.

Function and regulation of human copper-transporting ATPases.

Lutsenko S, Barnes NL, Bartee MY, Dmitriev OY.

Physiol Rev. 2007 Jul;87(3):1011-46. Review.

16.

Cyclooxygenase-2 inhibition: effects on tumour growth, cell cycling and lymphangiogenesis in a xenograft model of breast cancer.

Barnes NL, Warnberg F, Farnie G, White D, Jiang W, Anderson E, Bundred NJ.

Br J Cancer. 2007 Feb 26;96(4):575-82. Epub 2007 Feb 6.

17.

Potential use of COX-2-aromatase inhibitor combinations in breast cancer.

Bundred NJ, Barnes NL.

Br J Cancer. 2005 Aug;93 Suppl 1:S10-5. Review.

18.

Absence of HER4 expression predicts recurrence of ductal carcinoma in situ of the breast.

Barnes NL, Khavari S, Boland GP, Cramer A, Knox WF, Bundred NJ.

Clin Cancer Res. 2005 Mar 15;11(6):2163-8.

19.

Relationship between hormone receptor status and tumour size, grade and comedo necrosis in ductal carcinoma in situ.

Barnes NL, Boland GP, Davenport A, Knox WF, Bundred NJ.

Br J Surg. 2005 Apr;92(4):429-34.

PMID:
15736216
20.

Metallothionein isoform expression by breast cancer cells.

Barnes NL, Ackland ML, Cornish EJ.

Int J Biochem Cell Biol. 2000 Aug;32(8):895-903.

PMID:
10940647

Supplemental Content

Loading ...
Support Center